Literature DB >> 7580018

Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

T Levy1, Z Ben-Rafael.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580018     DOI: 10.1007/BF02212924

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  21 in total

1.  Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation.

Authors:  Z Ben-Rafael; J F Strauss; L Mastroianni; G L Flickinger
Journal:  Fertil Steril       Date:  1986-10       Impact factor: 7.329

2.  Stimulation protocols for patients with "atypical response".

Authors:  S J Muasher
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos.

Authors:  C O'Neill; A A Gidley-Baird; I L Pike; D M Saunders
Journal:  Fertil Steril       Date:  1987-06       Impact factor: 7.329

4.  The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.

Authors:  S J Muasher; S Oehninger; S Simonetti; J Matta; L M Ellis; H C Liu; G S Jones; Z Rosenwaks
Journal:  Fertil Steril       Date:  1988-08       Impact factor: 7.329

5.  Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.

Authors:  G Lavy; A Pellicer; M P Diamond; A H DeCherney
Journal:  Fertil Steril       Date:  1988-07       Impact factor: 7.329

6.  Pure follicle stimulating hormone does not enhance follicular recruitment in clomiphene citrate/gonadotropin combinations.

Authors:  M M Quigley; R L Collins; J Blankstein
Journal:  Fertil Steril       Date:  1988-10       Impact factor: 7.329

7.  The use of high-dose human menopausal gonadotropin in an in vitro fertilization program.

Authors:  N Laufer; A H DeCherney; F P Haseltine; M L Polan; H C Mezer; A M Dlugi; D Sweeney; F Nero; F Naftolin
Journal:  Fertil Steril       Date:  1983-12       Impact factor: 7.329

8.  The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.

Authors:  R E Bernardus; G S Jones; A A Acosta; J E Garcia; H C Liu; D L Jones; Z Rosenwaks
Journal:  Fertil Steril       Date:  1985-03       Impact factor: 7.329

9.  Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.

Authors:  J D Stanger; J L Yovich
Journal:  Br J Obstet Gynaecol       Date:  1985-04

10.  Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.

Authors:  J E Garcia; G S Jones; A A Acosta; G Wright
Journal:  Fertil Steril       Date:  1983-02       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.